Skip to content

Cardiorespiratory Assessment and Quality of Life After Surgical Correction of Congenital Wall Malformations

Cardiorespiratory Assessment and Quality of Life After Surgical Correction of Congenital Wall Malformations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03770390
Acronym
HeartSoar
Enrollment
43
Registered
2018-12-10
Start date
2018-12-16
Completion date
2024-12-31
Last updated
2025-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Funnel Chest

Brief summary

The main objective of this study is to characterize the cardiorespiratory functional gain in patients with pectus excavatum following corrective surgery.

Detailed description

The secondary objectives are: * To measure the quality of life of patients operated on for pectus excavatum * Identify and describe post-operative complications * Follow-up on the body mass index changes post-surgery * Evaluate intraoperative hemodynamic parameters before and after the retrosternal bar is placed non-invasively

Interventions

PROCEDURESurgical correction of pectus excavatum

Surgical correction of pectus excavatum

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This single group study documents changes before and after surgical correction of pectus excavatum.

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with pectus excavatum * The patient received corrective surgery within four years of enrollment and is scheduled for a follow-up visit --OR-- the patient is scheduled for corrective surgery during the inclusion period * Collection of informed written consent (patient and legal guardian, if applicable) * Obligation of affiliation or beneficiary of a social security programme

Exclusion criteria

* Impossibility for the patient to participate in his/her next annual follow-up visit * Absence of exercise test data AND respiratory function test data performed during the preoperative check-up * Subject in exclusion period required by another protocol * Pregnant or lactating woman, patient unable to give consent, protected adult, vulnerable persons (according to French Health Code articles L.1121-6, L.1121-7, L.1211-8, L.1211-9) * Subject deprived of liberty by judicial or administrative decision * Participation of the subject in another interventional protocol * Failure to properly inform the patient (e.g. a language barrier)

Design outcomes

Primary

MeasureTime frameDescription
Change in: Oxygen pulse (mL O2 / heart beat)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))Recorded during incremental exercise testing.

Secondary

MeasureTime frameDescription
Change in: The presence/absence of dyspnea during exercisepost-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: The presence/absence of palpitationspost-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: The presence/absence of psychosocial impactpost-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: VO2MAX (ml/kg/min)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))Maximum oxygen consumption during incremental exercise testing.
Change in: VO2MAX (% predicted)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))Maximum oxygen consumption during incremental exercise testing.
Change in: Maximum heart rate (bpm)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))Maximum heart rate during incremental exercise testing.
Change in: Presence/absence of an anomaly in oxygen pulsepost-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))Presence/absence of an anomaly in oxygen pulse during incremental exercise testing.
Change in: Ventilatory threshold (% of VO2MAX)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))The ventilatory threshold during incremental exercise testing.
Change in: Breathing Reserve (% of maximum voluntary ventilation)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))The breathing reserved during incremental exercise testing.
Change in: Forced expiratory volume in 1 second (liters)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Forced expiratory volume in 1 second (% predicted)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Forced vital capacity (liters)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Forced vital capacity (% predicted)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Forced expiratory volume in 1 second (litres) / forced vital capacity (litres)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Residual volume (liters)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Residual volume (% predicted)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Body mass index (kg/m^2)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Total lung capacity (% predicted)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Residual volume / Total lung capacity (liters/liters)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Functional residual capacity (liters)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
Change in: Functional residual capacity (% predicted)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))
The SF36 questionnairepost-op (expected maximum of 4 years)This is a general health related quality of life questionnaire.
The Body Esteem Scalepost-op (expected maximum of 4 years)This questionnaire treats body esteem.
The Rosenberg Self Esteem Scalepost-op (expected maximum of 4 years)This questionnaire treats self esteem.
Complicationsper-op up to expected maximum of 4 years
Blood pressure (average, mmHg)during surgery (day 0)Per-operative hemodynamic measures
Pulseduring surgery (day 0)Per-operative hemodynamic measures
Oxygen saturation (SpO2, %)during surgery (day 0)Per-operative hemodynamic measures
Cardiac index (liters/min/m^2)during surgery (day 0)Per-operative hemodynamic measures
Variation in ejection volume (%)during surgery (day 0)Per-operative hemodynamic measures
Indexed systolic ejection volume (ml/beat/m2)during surgery (day 0)Per-operative hemodynamic measures
Cumulative dose of vasopressorsduring surgery (day 0)Per-operative hemodynamic measures
Change in: Total lung capacity (liters)post-op (expected maximum of 4 years) versus pre-op (approximately month -1 up to day 0))

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026